간편하게 보는 뉴스는 유니콘뉴스
Parse Biosciences Launches Certified Service Provider Program

· 등록일 Jul. 12, 2024 11:30

· 업데이트일 2024-07-13 00:00:20

SEATTLE--(Business Wire / Korea Newswire)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of its Certified Service Provider (CSP) Program. For researchers who are seeking paths to outsource their single cell projects, Parse’s CSP Program provides options to partner with trusted service providers capable of running smaller pilot projects up to performing routine high throughput projects.

Fremont, California-based SeqMatic and Framingham, Massachusetts-based Eurofins Clinical Enterprise, LLC are the first CSPs to partner with Parse to offer its expanding portfolio of single cell products, including its Evercode™ Whole Transcriptome, Evercode™ TCR, CRISPR Detect, Gene Capture, and its recently released Evercode™ BCR, which captures full length BCR sequences and gene expression together at unprecedented scale.

“The advances we’re seeing as a result of single cell sequencing continue to transform scientific research,” noted Parse co-founder and CEO Alex Rosenberg. “The CSP Program is an important step in broadening access to scalable single cell sequencing, and we’re proud to have SeqMatic and Eurofins Clinical Enterprise join us as our first partners in this initiative.”

Comprehensive CSPs providing a full range of high quality end-to-end multi omics workflow solutions including DNA and RNA sequencing, SeqMatic and Eurofins Clinical Enterprise can manage samples from any US or international location, including multi-site collaborations and unique requirements. Their professional service provides assurance of expert handling, tracking and coordination of samples.

“SeqMatic is dedicated to providing the highest level of service and cutting edge technologies to our more than 700 customers in the US and around the world,” said SeqMatic CEO Len Goren. “We are excited to make Parse’s industry-leading single cell sequencing kits available to all of them.”

Partner companies like SeqMatic and Eurofins Clinical Enterprise that offer Parse’s kits as a service must meet Parse’s stringent criteria and provide the highest quality results to their clients. For more information about Parse’s CSP program, visit https://www.parsebiosciences.com/service-providers/. To learn more about SeqMatic’s Parse offerings, visit https://www.seqmatic.com/services/parse-biosciences-single-cell-rna-sequencing-service/, and to learn more about Eurofins Clinical Enterprise’s Parse offerings, visit https://clinicalenterprise.com/.

About Parse Biosciences

Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Founded based on a transformative technology invented at the University of Washington, Parse has raised over $100 million and is used in nearly 2,000 labs across the world. Its growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Evercode BCR, CRISPR Detect, Gene Capture, and a software tool for data analysis.

Headquartered in Seattle, Washington’s vibrant South Lake Union district, Parse Biosciences recently opened a 34,000 square foot headquarters and state-of-the-art laboratory.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240711445815/en/

Website: https://www.parsebiosciences.com/ Contact For Parse Biosciences
SRPR
Jay Roberts
917.696.2142
[email protected]
This news is a press release provided by Parse Biosciences. Korea Newswire follows these editorial guidelines. Parse Biosciences News ReleasesSubscribeRSS 파스 바이오사이언스, 인증 서비스 제공업체 프로그램 출시 접근 가능하고 확장 가능한 단일 세포 염기서열 분석 솔루션의 선두 공급업체인 파스 바이오사이언스(Parse Biosciences) 가 11일(현지 시간) 인증 서비스 제공업체(Certified Service Provider, CSP) 프로그램의 출시를 발표했다. 단일 세포 프로젝트를 아웃소싱할 방법을 찾고 있는 연구원들을 위해 파스의 ... 7월 12일 11:30 Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Trailmaker™, its user-friendly cloud platform purpose-built for single cell data analysis. Fast, scalable, and capable of providing end-to-end analysis... 5월 31일 15:05 ... More  More News Health Biotechnology New Product Overseas Parse Biosciences All News Releases 
인기 기사12.23 19시 기준
스킬맨, 뉴저지--(Business Wire / 뉴스와이어)--매출 기준 세계 최대의 순수 소비자 건강 회사인 켄뷰(Kenvue Inc.)(뉴욕증권거래소: KVUE)는 뉴욕에서 열리는 모건스탠리 글로벌 소비자 콘퍼런스 2023(Morgan Stanley’s Global Consumer & Retail Conference 2023)에 참가한다고 오늘 발표했다. 최고 경영자 겸...
CHICAGO--(Business Wire / Korea Newswire)--NielsenIQ (NIQ), the world’s leading consumer intelligence company, has released its second Environmental, Social and Governance (ESG) Progress Report detailing the Company’s ESG priorities, how it embeds inclusive, sustainable principles...
대전--(뉴스와이어)--레이저 및 에너지 기반 메디컬 솔루션을 제공하는 글로벌 기업 원텍(대표이사 김종원·김정현) 이 11월 15일부터 17일까지 홍콩에서 개최된 코스모프로프 아시아 2023(COSMOPROF ASIA 2023)에 참여했다. 코스모 프로프는 이탈리아, 볼로냐, 미국 라스베이거스 미용 박람회와 함께 세계 3대 미용...
서울--(뉴스와이어)--동남아와 대만 최대의 이커머스 플랫폼 쇼피코리아(지사장 권윤아, Shopee)가 국내 물류센터에 셀러들의 상품을 위탁받아 일괄 물류 대행 서비스를 제공하는 ‘국내 풀필먼트 서비스(Korea Fulfilled by Shopee, 이하 K-FBS)’를 론칭한다고 16일 밝혔다. ...
뉴욕--(Business Wire / 뉴스와이어)--모건 스탠리(Morgan Stanley)(NYSE: MS)가 오늘 북미 및 유럽·중동·아프리카(EMEA)의 23개 기업이 참여하는 최대 규모의 글로벌 데모 데이(Demo Day)를 개최한다. 코호트 회사는 300명 이상의 투자자와 잠재적인 비즈니스 파트너 및 고객을 대상으로 한다. 5개월...
서울--(뉴스와이어)--보도자료 배포 플랫폼 뉴스와이어를 운영하는 코리아뉴스와이어(대표이사 신동호)가 본사를 중구 서소문로 배재정동빌딩으로 이전했다고 17일 밝혔다. 뉴스와이어가 사무실을 이전한 배재정동빌딩 ...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.